 |
인쇄하기
취소
|
Allergan Korea launches new treatment for hypotrichosis of the eyelashes
Allergan Korea said it has launched LATISSE™ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
LATISSE is the first and only science-based treatment approved by the Korea Food and Drug Administration last July to enhance eyelash prominence as measured by inc...
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
LATISSE is the first and only science-based treatment approved by the Korea Food and Drug Administration last July to enhance eyelash prominence as measured by inc...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.